← Open Payments lookup

DOMINIQUE LEVEQUE: Open Payments

NPI 1285785584 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,293 in 237 payments from 20 companies in 2025. Trend: 2023 $3,640 · 2024 $4,139 · 2025 $5,293

Food & beverage: $5,081Education: $211
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.36$872
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$610
E.R. Squibb & Sons, L.L.C.18$491
Alkermes, Inc.25$405
Otsuka America Pharmaceutical, Inc.25$399
Vanda Pharmaceuticals Inc.15$361
Axsome Therapeutics, Inc.10$349
JAZZ PHARMACEUTICALS INC.13$332
Neurocrine BioSciences, Inc.11$303
ABBVIE INC.16$259

Products named: CAPLYTA, COBENFY, REXULTI, AUSTEDO XR, ARISTADA, HETLIOZ, Auvelity, EPIDIOLEX.

Industry payments across IN — which companies pay providers there.